1,2-icosapentoyl-sn-glycero-3-phosphoserine

DB14096ApprovedSmall molecule

1,2-icosapentoyl-sn-glycero-3-phosphoserine: Overview.

Chemical structure of 1,2-icosapentoyl-sn-glycero-3-phosphoserine
Formula / weight
C47H72NO10P · 842.064 g/mol (avg)
First approval
United States, 2015
Brand names
  • EnBrace HR
  • EnLyte

Resolves to

Compound
UNIIC3019D8IIA
Clinical / RWD
RxNorm1549117
Structure
InChIKeyWQVNGJIIARFEJV-XSLFZJRCSA-NSMILES[H]C(N)(COP(O)(=O)OCC([H])(COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)OC(=O)CCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)C(O)=O

What you can answer from here — as of August 30, 2026

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5Marketed productsAcross 1 country and 2 labellers
Sign in

Which companies are running trials of 1,2-icosapentoyl-sn-glycero-3-phosphoserine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In